Patent US3608086A successfully refreshed from Google Patents.
US3608086A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Treatment of dermatologic diseases employing aluminum propionate aluminum dipropionate and certain double acid salts thereof
Assignee: Synergistics Inc
•
Filing: 1968-11-01
•
Granted: 1971-09-21
•
Expires: 1988-11-01
Abstract
Abstract Double acid salts of aluminum propionate and aluminum dipropionate prepared with acetic acid, lactic acid, citric acid and tartaric acid, which are suitable for use in treating dermatologic disease.
Inventors
- 👤 Alfred Halpern
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 17:44
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
26 words
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of aluminum lacto propionate.
Claim 2
Dependent Claim
26 words
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of aluminum citro propionate.
Claim 3
Dependent Claim
26 words
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of aluminum tartaro propionate.
Claim 4
Dependent Claim
26 words
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and nor more than 30 percent by weight of aluminum aceto dipropionate.
Claim 5
Dependent Claim
26 words
A pharmaceutically composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of aluminum citro dipropionate.
Claim 6
Dependent Claim
26 words
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of aluminum tartaro dipropionate.
Claim 7
Dependent Claim
26 words
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of aluminum lacto dipropionate.
Claim 8
Independent Claim
75 words
A method of treating atopic dermatitis which comprises applying to the skin an effective amount of a composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more then 30 percent by weight of a compound selected from the group consisting of aluminum propionate, aluminum dipropionate, aluminum aceto propionate, aluminum citro propionate, aluminum lacto propionate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum citro dipropionate, aluminum lacto dipropionate, and aluminum tartaro dipropionate.
Claim 9
Independent Claim
73 words
A method of treating dermatologic pruritis which comprises applying to the skin on effective amount of a composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of a compound selected from the group consisting of aluminum dipropionate aluminum aceto propionate, aluminum citro propionate, aluminum lacto propionate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum citro dipropionate, aluminum lacto dipropionate, and aluminum tartaro dipropionate.
Claim 10
Independent Claim
76 words
A method of treating inflammation of the skin which comprises applying to the skin an effective amount of composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of a compound selected from the group consisting of aluminum propionate, aluminum dipropionate, aluminum aceto propionate, aluminum citro propionate, aluminum lacto propionate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum citro dipropionate, aluminum lacto dipropionate, and aluminum tartaro dipropionate.
Claim 11
Independent Claim
75 words
A method of treating eczematoid lesions which comprises applying to the skin an effective amount of a composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of a compound selected from the group consisting of aluminum propionate, aluminum dipropionate, aluminum aceto propionate, aluminum citro propionate, aluminum lacto propionate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum citro dipropionatE, aluminum lacto dipropionate, and aluminum tartaro dipropionate.
Claim 12
Independent Claim
76 words
A method of treating local skin infections which comprises applying to the skin an effective amount of a composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of a compound selected from the group consisting of aluminum propionate, aluminum dipropionate, aluminum aceto propionate, aluminum citro propionate, aluminum lacto propionate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum citro dipropionate, aluminum lacto dipropionate, and aluminum tartaro dipropionate.
Claim 13
Independent Claim
78 words
A method of treating exudative eruptive stages of dermatitides which comprises applying to the skin an effective amount of a composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of a compound selected from the group consisting of aluminum propionate, aluminum dipropionate, aluminum aceto propionate, aluminum citro propionate, aluminum lacto propionate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum citro dipropionate, aluminum lacto depropionate, and aluminum tartaro dipropionate.
Claim 14
Independent Claim
78 words
A method of treating vesicular eruptive stages of dermatitis which comprises applying to the skin and effective amount of a composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of a compound selected from the group consisting of aluminum propionate, aluminum dipropionate, aluminum aceto propionate, aluminum citro propionate, aluminum lacto propionate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum lacto dipropionate, aluminum citro dipropionate, and aluminum tartaro dipropionate.
Claim 15
Independent Claim
75 words
A method of treating dermatological fungal infections which comprises applying to the skin and effective amount of a composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of a compound selected from the group consisting of aluminum propionate, aluminum dipropionate, aluminum aceto propionate, aluminum citro propionate, aluminum lacto propinate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum citro dipropionate, aluminum lacto dipropionate, aluminum tartaro dipropionate.
Claim 16
Independent Claim
78 words
A method of alleviating the symptoms of contact dermatitis which comprises applying to the skin an effective amount of a composition comprising a pharamceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of a compound selected from the group consisting of aluminum propionate, aluminum dipropionate, aluminum aceto propionate, aluminum citro propionate, aluminum lacto propionate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum citro dipropionate, aluminum lacto dipropionate, and aluminum tartaro dipropionate.
Claim 17
Independent Claim
78 words
A method of alleviating the symptoms of allergic dermatitis which comprises applying to the skin and effective amount of a composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of a compound selected from the group consisting of aluminum propionate, aluminum dipropionate, aluminum aceto propionate, aluminum citro propionate, aluminum lacto propionate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum citro dipropionate, aluminum lacto dipropionate, and aluminum tartaro dipropionate.
Claim 18
Independent Claim
82 words
A method of inhibiting the enzymatic degradation of urea ammonia on skin surfaces which comprises applying to the skin an effective amount of a composition comprising a pharmaceutically acceptable carrier and not less than 2 percent and not more than 30 percent by weight of a compound selected from the group consisting of aluminum propionate, aluminum dipropionate, aluminum aceto propionate, aluminum citro propionate, aluminum lacto propionate, aluminum tartaro propionate, aluminum aceto dipropionate, aluminum citro dipropionate, aluminum lacto dipropionate and aluminum tartaro dipropionate.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1974-09-20 | 1975-03-22 | 1975-09-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1978-09-20 | 1979-03-22 | 1979-09-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1982-09-20 | 1983-03-22 | 1983-09-21 | $7700.00 | Window Closed / Lapsed |